Immediate effect of transcutaneous electrical nerve stimulation on the excitability of spinal motoneurons in post-stroke spasticity

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900028418

Enrollment

Unknown

Registered

2019-12-21

Start date

2019-12-31

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spasticity

Interventions

Three Groups:transcutaneous electrical nerve stimulation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary participation, the patient himself understands and signs or the legal guardian signs the informed consent form; 2. Conform to the diagnosis of stroke in Diagnostic Points of Various Cerebrovascular Diseases adopted by the Fourth National Conference on Cerebrovascular Diseases in 1995, and showed a single infarction or hemorrhage on the side by CT or MRI. kitchen; 3. The MAS score of the hemiplegia was >1, and the muscle tension of the healthy limb was normal; 4. The first occurrence of stroke or previous lacunar infarction without sequelae; 5. The onset time >=1 month; 6. Aged 18 to 80 years old, male or female, left or right; 7. The condition is stable, the consciousness is clear, and the vital signs are stable; 8. In the process of posture change,they don't have obvious discomfort, and they can tolerate sitting for 30 minutes.

Exclusion criteria

Exclusion criteria: 1. Patients who have Parkinson's disease and other high muscle tone; 2. Patients who have serious cognitive, verbal, visual, hearing or mental disorders and other effects of examination and treatment; 3. Patients who had a lacunar infarction and have sequelae; 4. Patients who have tumors, severe respiratory, heart, liver, kidney, endocrine and hematopoietic systems; 5. Patients who have joint with disease (such as joint surgery or rheumatoid arthritis); 6. There are contraindications for surface electromyography or transcutaneous electrical nerve stimulation (such as epidermal damage, fever, etc.); 7. Participating in other clinical trials.

Design outcomes

Primary

Measure	Time frame
Spasticity;	—

Secondary

Measure	Time frame
(post-activation depression;	—

Countries

China

Contacts

Public ContactFang Li

Department of Rehabilitation Medicine, Huashan Hospital, Fudan University

fangl@fudan.edu.cn+86 13370004556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026